Andreas Gerber - Publications, H-index & Citations

Andreas Gerber

University of Cologne

31H指数

199论文数

3.9K被引数

收录论文 19

发表时间

The 3-Machines Energy Transition Model: Exploring the Energy Frontiers for Restoring a Habitable Climate

EARTHS FUTURE

IF8.2

2022-10-26

OAAI

Desing, Harald; Gerber, Andreas; Hischier, Roland; Wager, Patrick; Widmer, Rolf

Games on Climate Change: Identifying Development Potentials through Advanced Classification and Game Characteristics Mapping

SUSTAINABILITY

IF3.3

2021-02-12

OAAI

Gerber, Andreas; Ulrich, Markus; Waeger, Flurin X.; Roca-Puigros, Marta; Goncalves, Joao S. V.; Waeger, Patrick

Short-Term Success versus Long-Term Failure: A Simulation-Based Approach for Understanding the Potential of Zambia's Fertilizer Subsidy Program in Enhancing Maize Availability

SUSTAINABILITY

IF3.3

2016-10-19

OAAI

Gerber, Andreas

Using the Analytic Hierarchy Process to Elicit Patient Preferences Prioritizing Multiple Outcome Measures of Antidepressant Drug Treatment

PATIENT-PATIENT CENTERED OUTCOMES RESEARCH

IF3.1

2012-12-01

PREAI

Hummel, Marjan J. M.; Volz, Fabian; van Manen, Jeannette G.; Danner, Marion; Dintsios, Charalabos-Markos; IJzerman, Maarten J.; Gerber, Andreas

VALUE IN HEALTH

IF6

2012-11-01

OAAI

Wagner, C. J.; Gerber, A.; Lhachimi, S. K.

COMMUNICATING TO DECISION MAKERS THE PARAMETER UNCERTAINTY IN THE IQWIG EFFICIENCY FRONTIER APPROACH

VALUE IN HEALTH

IF6

2012-11-01

OAAI

Stollenwerk, B.; Briggs, A.; Fenwick, E.; Caro, J. J.; Siebert, U.; Lhachimi, S. K.; Gerber, A.

GUIDELINES WITHOUT GUIDANCE: THE CASE OF EPIDEMIOLOGICAL DATA BEYOND CLINICAL TRIALS

VALUE IN HEALTH

IF6

2012-11-01

OAAI

Sandmann, F. G.; Herrmann, K. H.; Zhou, M.; Gerber, A.; Lhachimi, S. K.

HOW DO GLAUCOMA PATIENTS ASSESS DIFFERENT ASPECTS OF THEIR TREATMENT: AN ELICITATION OF PATIENTS' PREFERENCES USING THE ANALYTIC HIERARCHY PROCESS

VALUE IN HEALTH

IF6

2012-11-01

OAAI

Dintsios, C. M.; Scheibler, F. F.; Janssen, I; Gerber, A.; Chernyak, N.; Finger, R.

Is prevention of atopic eczema with hydrolyzed formulas cost-effective? A health economic evaluation from Germany

PEDIATRIC ALLERGY AND IMMUNOLOGY

IF4.5

2012-05-25

PREAI

Mertens, Janina; Stock, Stephanie; Luengen, Markus; v. Berg, Andrea; Kraemer, Ursula; Filipiak-Pittroff, Birgit; Heinrich, Joachim; Koletzko, Sibylle; Gruebl, Armin; Wichmann, H-Erich; Bauer, Carl-P; Reinhardt, Dietrich; Berdel, Dietrich; Gerber, Andreas

German Diabetes Management Programs Improve Quality Of Care And Curb Costs

HEALTH AFFAIRS

IF8.1

2010-12-01

PREAI

Stock, Stephanie; Drabik, Anna; Buescher, Guido; Graf, Christian; Ullrich, Walter; Gerber, Andreas; Lauterbach, Karl W.; Luengen, Markus

IS PREVENTION OF ATOPIC DERMATITIS WITH HYDROLYSATE FORMULAS COST-EFFECTIVE? AN APPLICATION OF RESULTS OF THE GINI-STUDY TO THE GERMAN SITUATION

PEDIATRIC RESEARCH

IF3.1

2010-11-01

OAAI

Mertens, J.; Stock, S.; Luengen, M.; von Berg, A.; Kraemer, U.; Filipiak-Pittroff, B.; Heinrich, J.; Koletzko, S.; Gruebl, A.; Wichmann, H. -E.; Bauer, C. -P.; Reinhardt, D.; Berdel, D.; Gerber, A.

Financial incentives in the German Statutory Health Insurance: New findings, new questions

HEALTH POLICY

IF3.4

2010-06-01

PREAI

Stock, Stephanie; Schmidt, Harald; Buescher, Guido; Gerber, Andreas; Drabik, Anna; Graf, Christian; Luengen, Markus; Stollenwerk, Bjoern

The German Coronary Artery Disease Risk Screening Model: Development, Validation, and Application of a Decision-Analytic Model for Coronary Artery Disease Prevention with Statins

MEDICAL DECISION MAKING

IF2.3

2009-09-22

PREAI

Stollenwerk, Bjoern; Gerber, Andreas; Lauterbach, Karl W.; Siebert, Uwe